Skip to content
Disclosery

GENERAL ATLANTIC, L.P.

Follow

13F filer, CIK 1017645, New York, NY

GENERAL ATLANTIC, L.P. reported $2,906,996,055 across 12 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 98.97% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-26-002338

Period
2026-06-30
Reported value
$2.91B
Holdings
12
Top 10 weight
98.97%
New
3
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LFTOnew+25,315,646$608M
SPTXnew+6,101,582$133M
ALKTadded+4,041,543$73.2M
PBLSnew+1,538,461$42.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EWCZexited-13,110,492-$75.8M
RVMDreduced-350,000-$65.5M
CNTAexited-1,354,830-$53.8M
PHVSreduced-1,480,495-$51.2M
NRIXreduced-1,069,680-$26M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000950142-26-002338, largest first. % of portfolio is the value over $2,906,996,055, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LFTOLIFTOFF MOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 25,315,646 shares 25,315,646$608M20.92%newTimeline
DLODLOCAL LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 63,906,695 shares; 2024Q4: 63,906,695 shares; 2025Q1: 63,906,695 shares; 2025Q2: 63,906,695 shares; 2025Q3: 46,656,695 shares; 2025Q4: 46,656,695 shares; 2026Q1: 46,656,695 shares; 2026Q2: 46,656,695 shares 46,656,695$606M20.86%0Timeline
CHYMCHIME FINL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 19,208,760 shares; 2025Q3: 19,208,760 shares; 2025Q4: 21,259,683 shares; 2026Q1: 21,259,683 shares; 2026Q2: 21,259,683 shares 21,259,683$435M14.98%0Timeline
ALKTALKAMI TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,520,318 shares; 2024Q4: 9,645,318 shares; 2025Q1: 9,645,318 shares; 2025Q2: 9,645,318 shares; 2025Q3: 11,991,480 shares; 2025Q4: 11,991,480 shares; 2026Q1: 15,337,495 shares; 2026Q2: 19,379,038 shares 19,379,038$351M12.08%+4,041,543Timeline
XPXP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 29,617,733 shares; 2024Q4: 29,617,733 shares; 2025Q1: 29,617,733 shares; 2025Q2: 25,517,733 shares; 2025Q3: 25,517,733 shares; 2025Q4: 22,699,133 shares; 2026Q1: 20,566,133 shares; 2026Q2: 20,566,133 shares 20,566,133$334M11.5%0Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,531,252 shares; 2024Q4: 7,531,252 shares; 2025Q1: 7,531,252 shares; 2025Q2: 7,531,252 shares; 2025Q3: 8,031,252 shares; 2025Q4: 8,031,252 shares; 2026Q1: 8,031,252 shares; 2026Q2: 6,550,757 shares 6,550,757$227M7.79%-1,480,495Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,101,582 shares 6,101,582$133M4.56%newTimeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,897,159 shares; 2026Q1: 4,101,865 shares; 2026Q2: 3,032,185 shares 3,032,185$73.6M2.53%-1,069,680Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,474,428 shares; 2025Q4: 2,812,928 shares; 2026Q1: 707,791 shares; 2026Q2: 357,791 shares 357,791$67M2.31%-350,000Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,538,461 shares 1,538,461$42.1M1.45%newTimeline
RSKDRISKIFIED LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,324,998 shares; 2024Q4: 5,324,998 shares; 2025Q1: 5,324,998 shares; 2025Q2: 5,324,998 shares; 2025Q3: 5,324,998 shares; 2025Q4: 5,324,998 shares; 2026Q1: 5,324,998 shares; 2026Q2: 5,324,998 shares 5,324,998$26.8M0.92%0Timeline
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 936,020 shares; 2024Q4: 2,474,859 shares; 2025Q1: 2,474,859 shares; 2025Q2: 2,474,859 shares; 2025Q3: 2,474,859 shares; 2025Q4: 2,474,859 shares; 2026Q1: 2,474,859 shares; 2026Q2: 2,474,859 shares 2,474,859$3.09M0.11%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
EWCZEUROPEAN WAX CTR INC13,110,492$75.8Mshares
CNTACENTESSA PHARMACEUTICALS PLC1,354,830$53.8Mshares
BULLWEBULL CORP50,816$244Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950142-26-002338 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000950142-26-002338 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0000950142-26-001406 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0000950142-26-000395 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0000950142-25-002960 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0000950142-25-002176 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0000950142-25-001365 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0000950142-25-000283 Quarter ended 2024-12-312025-02-07acceptance time not in the bulk data set
13F-HR 0000950142-24-002746 Quarter ended 2024-09-302024-11-12acceptance time not in the bulk data set
13F-HR 0000950142-24-002199 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0000950142-24-001354 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0000950142-24-000388 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0000950142-23-002778 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0000950142-23-002206 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-HR 0000950142-23-001453 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0000950142-23-000392 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0000950142-22-003169 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0000950142-22-002502 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0000950142-22-001636 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0000950142-22-000625 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0000950142-21-003709 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0000950142-21-002611 Quarter ended 2021-06-302021-08-13acceptance time not in the bulk data set
13F-HR 0000950142-21-001634 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0000950142-21-000530 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set
13F-HR 0000950142-20-002516 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0000950142-20-002017 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0000950142-20-001351 Quarter ended 2020-03-312020-05-14acceptance time not in the bulk data set
13F-HR 0000950142-20-000443 Quarter ended 2019-12-312020-02-13acceptance time not in the bulk data set
13F-HR 0000950142-19-002279 Quarter ended 2019-09-302019-11-13acceptance time not in the bulk data set
13F-HR 0000950142-19-001762 Quarter ended 2019-06-302019-08-13acceptance time not in the bulk data set
13F-HR 0000950142-19-001086 Quarter ended 2019-03-312019-05-14acceptance time not in the bulk data set
13F-HR 0000950142-19-000203 Quarter ended 2018-12-312019-02-11acceptance time not in the bulk data set
13F-HR 0000950142-18-002185 Quarter ended 2018-09-302018-11-13acceptance time not in the bulk data set
13F-HR 0000950142-18-001747 Quarter ended 2018-06-302018-08-13acceptance time not in the bulk data set
13F-HR 0000950142-18-001156 Quarter ended 2018-03-312018-05-11acceptance time not in the bulk data set
13F-HR 0000950142-18-000422 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0000950142-17-002016 Quarter ended 2017-09-302017-11-13acceptance time not in the bulk data set
13F-HR 0000950142-17-001511 Quarter ended 2017-06-302017-08-11acceptance time not in the bulk data set
13F-HR 0000950142-17-001029 Quarter ended 2017-03-312017-05-12acceptance time not in the bulk data set
13F-HR 0000950142-17-000287 Quarter ended 2016-12-312017-02-10acceptance time not in the bulk data set
13F-HR 0000950142-16-004724 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR/A 0000950142-16-004316 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0000950142-16-004310 Quarter ended 2016-06-302016-08-12acceptance time not in the bulk data set
13F-HR 0000950142-16-003722 Quarter ended 2016-03-312016-05-13acceptance time not in the bulk data set
13F-HR 0000950142-16-003075 Quarter ended 2015-12-312016-02-12acceptance time not in the bulk data set
13F-HR 0000950142-15-002416 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0000950142-15-001924 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0000950142-15-001073 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0000950142-15-000337 Quarter ended 2014-12-312015-02-13acceptance time not in the bulk data set
13F-HR 0000950142-14-002233 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0000950142-14-001705 Quarter ended 2014-06-302014-08-08acceptance time not in the bulk data set
13F-HR 0000950142-14-001046 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0000950142-14-000381 Quarter ended 2013-12-312014-02-13acceptance time not in the bulk data set
13F-HR 0000950142-13-002207 Quarter ended 2013-09-302013-11-08acceptance time not in the bulk data set
13F-HR 0000950142-13-001792 Quarter ended 2013-06-302013-08-09acceptance time not in the bulk data set